To evaluate the potential impact of anemia on the comparison of iron-related biomarkers, we repeated the comparison between CRC patients and healthy controls but considering only non-anemic individuals (defined as Hb ≥ 12 g/dL in women and ≥13 g/dL in men). The gene discussed is GSTM1; the disease is anemia.